Key facts
- Citizen Health’s last known valuation is $156.5M (Aug 2025).
- It has raised $44.5M; the latest was Later Stage VC ($30.0M) in Aug 2025.
- Notable investors include 8VC, Headline, Transformation Capital, Chan Zuckerberg Initiative, Wavemaker360.
- Status: Acquired/Merged (Operating Subsidiary).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Citizen Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Citizen Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Citizen Health
Developer of an AI-powered patient data platform designed to optimize rare disease care management and research advancement. The company's platform aggregates and unifies comprehensive, longitudinal medical records, including clinical notes, imaging, genetics, and outcomes data, with regulatory-grade compliance, provides secure patient-controlled data access, supports real-time question answering, enabling rare disease patients and their families to efficiently understand and share medical history, improving access to tailored care insights and research opportunities.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2017
- Employees
- 19
- Website
- citizen.health/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Citizen Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Citizen Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Citizen Health in its N-PORT filings yet. We sweep new filings monthly.